The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
A review of CETP and its relation to atherosclerosis
Open accessAbstract
Although the atheroprotective role of HDL cholesterol (HDL-c) is well documented, effective therapeutics to selectively increase plasma HDL-c levels are not yet available. Recent progress in unraveling human HDL metabolism has fuelled the development of strategies to decrease the incidence and progression of coronary artery disease (CAD) by raising HDL-c. In this quest for novel drugs, cholesteryl ester transfer protein (CETP) represents a pivotal target. The role of this plasma protein in HDL metabolism is highlighted by the discovery that genetic CETP deficiency is the main cause of high HDL-c levels in Asian populations. The use of CETP inhibitors to effectively increase HDL-c concentration in humans was recently published and data with regard to the effect on human atherosclerosis are expected shortly. This review discusses the potential of CETP inhibitors to protect against atherosclerosis in the context of the current knowledge of CETP function in both rodents and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410050061031 · Cited by 957
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 870
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors
McGovern, P. G., Pankow, J. S., Shahar, E., Doliszny, K. M., Folsom, A. R., Blackburn, H., & Luepker, R. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341403 · Cited by 699
von Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
PLASMA LIPID TRANSFER PROTEINS
Tall, A. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639
Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 625
Self-citationHDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
Barzilai, N. (2003) · JAMA · doi:10.1001/jama.290.15.2030 · Cited by 575
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494
de Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F. H., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000015857.31889.7b · Cited by 456
Self-citationSevere atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
Marotti, K. R., Castle, C. K., Boyle, T. P., Lin, A. H., Murray, R. W., & Melchior, G. W. (1993) · Nature · doi:10.1038/364073a0 · Cited by 445
Ordovas, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. F., & Schaefer, E. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1323 · Cited by 379
Plasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377
Clark, R. W., Sutfin, T. A., Ruggeri, R. B., Willauer, A. T., Sugarman, E. D., Magnus-Aryitey, G., Cosgrove, P. G., Sand, T. M., Wester, R. T., Williams, J. A., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118278.21719.17 · Cited by 371
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study
Després, J.-P., Lemieux, I., Dagenais, G.-R., Cantin, B., & Lamarche, B. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00603-1 · Cited by 316
Atheroprotective mechanisms of HDL
Stein, O., & Stein, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00065-9 · Cited by 316
Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 312
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Rye, K.-A., & Barter, P. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000104029.74961.f5 · Cited by 309
Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D., & Marques-Vidal, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118207 · Cited by 301
Bisoendial, R. J., Hovingh, G. K., Levels, J. H. M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J. P., & Stroes, E. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000070934.69310.1a · Cited by 288
Self-citationHirano, K.-I., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., & Matsuzawa, Y. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1053 · Cited by 275
Hayek, T., Masucci-Magoulas, L., Jiang, X., Walsh, A., Rubin, E., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 265
Koizumi, J., Mabuchi, H., Yoshimura, A., Michishita, I., Takeda, M., Itoh, H., Sakai, Y., Sakai, T., Ueda, K., & Takeda, R. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90064-4 · Cited by 248
Sugano, M., Makino, N., Sawada, S., Otsuka, S., Watanabe, M., Okamoto, H., Kamada, M., & Mizushima, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5033 · Cited by 241
High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway
Xia, P., Vadas, M. A., Rye, K.-A., Barter, P. J., & Gamble, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33143 · Cited by 233
Föger, B., Chase, M., Amar, M. J., Vaisman, B. L., Shamburek, R. D., Paigen, B., Fruchart-Najib, J., Paiz, J. A., Koch, C. A., Hoyt, R. F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.36912 · Cited by 224
Arteriosclerosis, Thrombosis, and Vascular Biology , 2004
Heistad, D. D. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000112102.28859.39 · Cited by 224
Plump, A. S., Masucci-Magoulas, L., Bruce, C., Bisgaier, C. L., Breslow, J. L., & Tall, A. R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1105 · Cited by 221
McPherson, R., Mann, C. J., Tall, A. R., Hogue, M., Martin, L., Milne, R. W., & Marcel, Y. L. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.797 · Cited by 215
Acton, S., Osgood, D., Donoghue, M., Corella, D., Pocovi, M., Cenarro, A., Mozas, P., Keilty, J., Squazzo, S., Woolf, E. A., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1734 · Cited by 213
Kuivenhoven, J. A., de Knijff, P., Boer, J. M. A., Smalheer, H. A., Botma, G.-J., Seidell, J. C., Kastelein, J. J. P., & Pritchard, P. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.560 · Cited by 210
Self-citationAshby, D. T., Rye, K.-A., Clay, M. A., Vadas, M. A., Gamble, J. R., & Barter, P. J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1450 · Cited by 200
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Hannuksela, M., Marcel, Y., Kesäniemi, Y., & Savolainen, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41437-3 · Cited by 192
Tall, A., Granot, E., Brocia, R., Tabas, I., Hesler, C., Williams, K., & Denke, M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112940 · Cited by 191
Freeman, D. J., Griffin, B. A., Holmes, A. P., Lindsay, G. M., Gaffney, D., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.336 · Cited by 188
Hirano, K.-I., Yamashita, S., Kuga, Y., Sakai, N., Nozaki, S., Kihara, S., Arai, T., Yanagi, K., Takami, S., Menju, M., et al. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1849 · Cited by 178
Moriyama, Y., Okamura, T., Inazu, A., Doi, M., Iso, H., Mouri, Y., Ishikawa, Y., Suzuki, H., Iida, M., Koizumi, J., et al. (1998) · Preventive Medicine · doi:10.1006/pmed.1998.0340 · Cited by 170
Dachet, C., Poirier, O., Cambien, F., Chapman, J., & Rouis, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.507 · Cited by 168
Ikewaki, K., Rader, D. J., Sakamoto, T., Nishiwaki, M., Wakimoto, N., Schaefer, J. R., Ishikawa, T., Fairwell, T., Zech, L. A., & Nakamura, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116750 · Cited by 166
Goff, W. L., Guérin, M., & Chapman, M. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.001 · Cited by 162
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
Boekholdt, S. M., & Thompson, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200018-jlr200 · Cited by 162
Brousseau, M. E., O’Connor, J. J., Ordovás, J. M., Collins, D. E., Otvos, J. D., Massov, T., McNamara, J. R., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024566.57589.2e · Cited by 149
Exercise training decreases plasma cholesteryl ester transfer protein.
Seip, R. L., Moulin, P., Cocke, T., Tall, A. R., Kohrt, W. M., Mankowitz, K., Semenkovich, C. F., Ostlund, R. E., & Schonfeld, G. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.9.1359 · Cited by 147
Bruce, C., Sharp, D. S., & Tall, A. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33876-1 · Cited by 147
Corbex, M. A., Poirier, O., Fumeron, F., Betoulle, D., Evans, A., Ruidavets, J. B., Arveiler, D., Luc, G., Tiret, L., & Cambien, F. (2000) · Genetic Epidemiology · doi:10.1002/1098-2272(200007)19:1<64::aid-gepi5>3.0.co;2-e · Cited by 144
Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
Barter, P. J. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00041-7 · Cited by 138
Naqvi, T. Z., Shah, P. K., Ivey, P. A., Molloy, M. D., Thomas, A. M., Panicker, S., Ahmed, A. E. E., Cercek, B., & Kaul, S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00489-0 · Cited by 134
Freeman, D. J., Griffin, B. A., Murray, E. F., Lindsay, G. M., Gaffney, D., Packard, C. J., & SHEPHERD, J. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00724.x · Cited by 133
Whitlock, M. E., Swenson, T. L., Ramakrishnan, R., Leonard, M., Marcel, Y. L., Milne, R. W., & Tall, A. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114132 · Cited by 126
Klerkx, A. H. E. M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg013 · Cited by 123
Self-citationYamashita, S., Matsuzawa, Y., Okazaki, M., Kako, H., Yasugi, T., Akioka, H., Hirano, K., & Tarui, S. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90094-9 · Cited by 120
Savolainen, M. J., Hannuksela, M. L., Seppänen, S., Kervinen, K., & Kesäniemi, Y. A. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01906.x · Cited by 117
Huang, Z., Inazu, A., Nohara, A., Higashikata, T., & Mabuchi, H. (2002) · Clinical Science · doi:10.1042/cs1030587 · Cited by 116
Dullaart, R. P. F., Hoogenberg, K., Dikkeschei, B. D., & van Tol, A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1581 · Cited by 116
Freeman, D. J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.001 · Cited by 114
Gotto, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.17.2213 · Cited by 114
Osgood, D. P., Corella, D., Demissie, S., Cupples, L. A., Wilson, P. W. F., Meigs, J. B., Schaefer, E. J., Coltell, Ó., & Ordovás, J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021664 · Cited by 113
Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia.
Bagdade, J. D., Ritter, M. C., & Subbaiah, P. V. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115127 · Cited by 110
Klerkx, A. H. E. M., de Grooth, G. J., Zwinderman, A. H., Jukema, J. W., Kuivenhoven, J. A., & Kastelein, J. J. P. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01281.x · Cited by 103
Self-citationMoulin, P., Gb, A., Ginsberg, H. N., & Tall, A. R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41339-2 · Cited by 103
van Venrooij, F. V., Stolk, R. P., Banga, J.-D., Sijmonsma, T., van Tol, A., Erkelens, D. W., Dallinga‐Thie, G. M., & for the DALI study group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1216 · Cited by 102
Sakai, N., Matsuzawa, Y., Hirano, K., Yamashita, S., Nozaki, S., Ueyama, Y., Kubo, M., & Tarui, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.71 · Cited by 101
Exercise training decreases plasma cholesteryl ester transfer protein.
LSeip, R., PMoulin, TCocke, ATall, MKohrt, W., KMankowitz, FSemenkovich, C., ROstlund, & GSchonfeld (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 101
Ikewaki, K., Nishiwaki, M., Sakamoto, T., Ishikawa, T., Fairwell, T., Zech, L. A., Nagano, M., Nakamura, H., Brewer, H. B., & Rader, D. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118196 · Cited by 97
Corella, D., Sáiz, C., Guillén, M., Portolés, O., Mulet, F., González, J. I., & Ordovás, J. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00477-3 · Cited by 90
Liu, S., Schmitz, C., Stampfer, M. J., Sacks, F. M., Hennekens, C. H., Lindpaintner, K., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00673-6 · Cited by 88
Blankenberg, S., Rupprecht, H. J., Bickel, C., Jiang, X., Poirier, O., Lackner, K. J., Meyer, J., Cambien, F., & Tiret, L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00408-x · Cited by 88
de Grooth, G. J., Smilde, T. J., van Wissen, S., Klerkx, A. H. E. M., Zwinderman, A. H., Fruchart, J., Kastelein, J. J. P., Stalenhoef, A. F. H., & Kuivenhoven, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.020 · Cited by 85
Self-citationDown-regulation of the low-density lipoprotein receptor by dietary cholesterol
D, A.-B., S M, H., E, H., K H, L., J J, A., & W R, H. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.3.360 · Cited by 85
Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol
Föger, B., Ritsch, A., Doblinger, A., Wessels, H., & Patsch, J. R. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1430 · Cited by 81
Shinkai, H., Maeda, K., Yamasaki, T., Okamoto, H., & Uchida, I. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000224s · Cited by 75
de Grooth, G. J., Zerba, K. E., Huang, S., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.056 · Cited by 66
Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity
Matsuzawa, Y., Yamashita, S., KAMEDA, K., Kubo, M., Tarui, S., & Hara, I. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90196-5 · Cited by 60
Sakai, N., Yamashita, S., Hirano, K., Ishigami, M., Arai, T., Kobayashi, K., Funahashi, T., & Matsuzawa, Y. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01710.x · Cited by 60
Kakko, S., Tamminen, M., Päivänsalo, M. J., Kauma, H., Rantala, A. O., Lilja, M., Reunanen, A., Kesäniemi, Y. A., & Savolainen, M. J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00859.x · Cited by 59
Vohl, M.-C., Lamarche, B., Pascot, A., Leroux, G., Prud’homme, D., Bouchard, C., Nadeau, A., & Després, J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800972 · Cited by 58
Bernard, S., Moulin, P., Lagrost, L., Picard, S., Elchebly, M., Ponsin, G., Chapuis, F. R., & Berthézène, F. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34203-6 · Cited by 54
Goto, A., Sasai, K., Suzuki, S., Fukutomi, T., Ito, S., Matsushita, T., Okamoto, M., Suzuki, T., Itoh, M., Okumura‐Noji, K., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00476-2 · Cited by 52
Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition
Gaynor, B. J., Sand, T. M., Clark, R. W., Aiello, R. J., Bamberger, M. J., & Moberly, J. B. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90073-6 · Cited by 43
Meguro, S., Takei, I., Murata, M., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00606-7 · Cited by 42
Kothari, H. V., Poirier, K., Lee, W. H., & Satoh, Y. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05981-3 · Cited by 37
Effects of blocking plasma lipid transfer protein activity in the rabbit
Abbey, M., & Calvert, G. D. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90093-3 · Cited by 37
Evans, G. F., Bensch, W. R., Apelgren, L. D., Bailey, D., Kauffman, R. F., Bumol, T. F., & Zuckerman, S. H. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41161-7 · Cited by 35
Sparks, D. L., Frohlich, J., Lacko, A. G., & Pritchard, P. H. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90080-4 · Cited by 29
Cited by
HDL and cardiovascular disease
Rader, D. J., & Hovingh, G. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61217-4 · Cited by 870
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Unraveling the complexities of the HDL lipidome
Kontush, A., Lhomme, M., & Chapman, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036095 · Cited by 396
Metadata
- Authors
- de Grooth, G. J., Klerkx, A. H. E. M., Stroes, E. S. G., Stalenhoef, A. F. H., Kastelein, J. J. P., & Kuivenhoven, J. A.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 45
- Issue
- 11
- Pages
- 1967-1974
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2146109620
- Cited by
- 269
- References
- 100
- FWCI
- 20.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.